Friday October 20, 2017 06:56

Heathcare Press Release : 13 Jun 2017

Guger Technologies OG - mindBEAGLE: The First EEG-based BCI System Ever for Communication with Heathcare—13 Jun 17

Frontiers in Neuroscience recently published an article presenting mindBEAGLE as the very first and only EEG-based Brain-Computer Interface (BCI) that enables communication with patients who suffer from locked-in syndrome (LIS), complete locked-in

New LEADER Analysis Shows Victoza(R) Reduces Cardiovascular Risk in People With Type 2 Diabetes Heathcare—13 Jun 17

Findings from a post hoc analysis of the LEADER cardiovascular (CV) outcomes trial showed that treatment with Victoza(R) (liraglutide) resulted in similar reductions in the risk of major cardiovascular events in people with type 2 diabetes at high CV

Tresiba(R) Demonstrated No Increased Risk Of Major Cardiovascular Events and Significant Reduction Heathcare—13 Jun 17

Novo Nordisk today announced the primary results from DEVOTE - the first randomised, double-blind, treat-to-target, event-driven trial comparing two basal insulins, Tresiba(R) (insulin degludec injection 100 U/mL) and insulin glargine U100, in adults